Clinical Research Directory

Inclusion Criteria: * Low back pain lasting for 3 months or more * Pain VAS score of 4 or higher * Three or more positive results in sacroiliac joint provocation tests * At least 50% pain relief following ultrasound-guided sacroiliac joint injection with local anesthetic Exclusion Criteria: * Currently undergoing extracorporeal shockwave therapy in other areas * Suspected pain caused by other lumbar spine or hip joint conditions (e.g., lumbar spine or disc disorders, radicular pain, spondylolisthesis/disc degeneration, hip arthritis) * Presence of complex comorbidities, including trauma, systemic infections (e.g., fever, chills, night sweats), local sacroiliac joint infections, autoimmune diseases, or immunosuppression * Sacroiliac joint injection therapy received within the past 6 months * Contraindications for extracorporeal shockwave therapy (e.g., cancer or current/prior infections at the treatment site, pacemakers, pregnancy, epilepsy, or coagulation disorders caused by disease or medication) * Impaired renal function preventing the administration of contrast agents for sacroiliac joint bone scanning